期刊文献+

艾司洛尔对维库溴铵/阿曲库铵肌松时效的影响

Effect of esmolol on time-response relationships of vecuronium and atracurium
下载PDF
导出
摘要 目的探讨艾司洛尔对维库溴铵、阿曲库铵肌松时效的影响。方法45例ASA(Ⅰ,Ⅱ)级择期手术的全麻患者,随机分为4组,Ⅰ组10例,静注维库溴铵0.1mg/kg(2×ED95);Ⅲ组10例,静注阿曲库铵0.5mg/kg(2×ED95);心率超过基础值的30%时,Ⅱ组15例,Ⅳ组10例,均给予艾司洛尔2mg/kg,用生理盐水稀释至5ml,10秒左右静注,1min后分别静注与Ⅰ组、Ⅲ组同等剂量的维库溴铵或阿曲库铵。用Biometer加速度仪监测肌松情况。结果Ⅰ组与Ⅱ组维库溴铵T190%恢复时间(min)分别为49.9±12.2和60.6±8.8,Ⅱ组明显延长(P<0.05);Ⅲ组与Ⅳ组阿曲库铵T190%恢复时间(min)分别为54.8±6.5和66.3±14.2,Ⅳ组明显延长(P<0.05),两组恢复指数(min)分别为10.6±2.3和17.9±7.0,Ⅳ组明显延长(P<0.01),其余各指标Ⅰ组与Ⅱ组相比,Ⅲ组与Ⅳ组相比,差异均无统计学意义。结论艾司洛尔能延长维库溴铵、阿曲库铵T190%恢复时间以及阿曲库铵的恢复指数。 Objective: To investigate the effect of esmolol on the time-response relationships of vecuronium and atracurium. Methods: Forty-five ASA grade Ⅰ, Ⅱ patients undergoing elective surgical operations were randomly allocated to four groups. A single dose of vecuronium was intravenously administered at twice ED95 (0.1 mg/kg) in goup Ⅰ( n =10) and combined with esmolol 2 mg/kg in goup Ⅱ(n =15). Atracurium was given at the dose of twice ED95 (0.5 mg/kg) in group Ⅲ(n =10 ) and combined with esmolol 2 mg/kg in group Ⅳ(n =10). Neuromuscular function was monitored with biometer accelograph. Results: T190% recobery times of vecuronium in group Ⅰand group Ⅱ were 49.9, 60.6 min respectively (P <0.05). T190% recobery times of atracurium was 54.8 in group Ⅲ and 66.3 min in group Ⅳ (P <0.05). Recovery index were 10.6 and 17.9 min in group Ⅲ and group Ⅳ, respectively (P <0.01). Conclusions: It is inducated that esmlolo can potentiate the time-response relationships of vecurorium and atracurium.
作者 穆娅玲 张宏
出处 《中国现代医学杂志》 CAS CSCD 2004年第16期115-117,共3页 China Journal of Modern Medicine
关键词 艾司洛尔 维库溴铵 阿曲库铵 药物相互作用 esmolol vecurorium atracuium drug interaction
  • 相关文献

参考文献9

  • 1Baird WLM, Bowman WC, Kerr WJ. Some actions of ORG NC 45 and of edrophonium in anaesthetized cat and man [J]. Br J Anaesth, 1982, 54: 375-385.
  • 2Ward S, Neill EAM, Weatherley BC, et al. Pharmacokinetics of atracurium besylate in healthy patients (after a single I .v. bolus dose)[J]. Br J Anaesth, 1983, 55: 113-117.
  • 3Stenlake JB, Waigh RD, Urwin J, et al. Atracurium; conception and inception[J]. Br J Anaesth, 1983, 55: 53-60.
  • 4Agoston S, Vandenbrom RHG, Mark J. Clinical pharmacokinetics of neuromuscular blocking drugs[J]. Clin Pharmacokinet, 1992, 22(2): 94-115.
  • 5Sum CR, Yacobi A, Kartzinel R, et al. Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite [J].Clin Pharmacol Ther, 1983, 34: 427-434.
  • 6Murthy VS, Patel KD, Elangovzn RG, et al. Cardiovascular and neuromuscular effects of esmolol during induction of anesthesia[J].Journal of Clinical Pharmacology, 1986, 26: 351-357.
  • 7Kim KS, Kim KH, Shin WJ, et al. Neuromuscular interactions between mivacurium and esmolol in rabbits [J]. Anaesthesia,1998, 53: 140-145.
  • 8费尔德曼 著 吴新民译.肌肉松弛药[M].北京:科学出版社,1998.128-134.
  • 9何小京,陈爱武,朱容.艾司洛尔及硝酸甘油对气管拔管时循环副反应的临床观察[J].中国现代医学杂志,2003,13(9):120-121. 被引量:7

二级参考文献4

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部